Janux Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $356.1M | $55.1M |
| Jun 2022 | — | $343.8M | $58.4M |
| Sep 2022 | — | $331.5M | $64.8M |
| Dec 2022 | — | $320.7M | $51.4M |
| Mar 2023 | — | $311.3M | $30.4M |
| Jun 2023 | — | $299.5M | $33.7M |
| Sep 2023 | — | $348.9M | $17.2M |
| Dec 2023 | — | $344.3M | $19.2M |
| Mar 2024 | — | $655.8M | $212.8M |
| Jun 2024 | — | $657.7M | $14.7M |
| Sep 2024 | — | $656.1M | $26.8M |
| Dec 2024 | — | $1.02B | $430.6M |
| Mar 2025 | — | $1.01B | $73.7M |
| Jun 2025 | — | $990.5M | $52.4M |
| Sep 2025 | — | $976.6M | $48.4M |
| Dec 2025 | — | $956.8M | $52.3M |
| Mar 2026 | — | $941.5M | $51.8M |
| Jun 2026 | — | $928.0M | $27.8M |